Sat, Jul 22, 2017 | updated 12:54 PM IST

Drug found to treat rare genetic disorder

Updated: Aug 31, 2016 17:44 IST      
Drug found to treat rare genetic disorder

WashingtonD.C.[USA], Aug. 31 (ANI): In a recent study researchers have discovered a type of drug delivery system that may offer new hope for patients with a rare, ultimately fatal genetic disorder Niemann Pick Type C1 and make what might become a terrible choice a little easier.

No treatment currently exists for this disease that affects about one in every 120,000 children globally, and results in abnormal cholesterol accumulation, progressive neurodegeneration and eventual death.

However, a compound that shows promise is now undergoing clinical trials, but it has major drawbacks, the high doses necessary also cause significant hearing loss and lung damage, as well as requiring direct brain injection.

New findings outline the potential for a nanotech-based delivery system to carry the new drug into cells far more effectively, improve its efficacy by about five times, and allow use of much lower doses that may still help treat this condition without causing such severe hearing loss.

The same system may ultimately show similar benefits for 50 or more other genetic disorders, especially those that require "brain targeting" of treatments.

Professor Gaurav Sahay said, "Right now there's nothing that can be done for patients with this disease, and the median survival time is 20 years."

Adding, "The new cholesterol-scavenging drug proposed to treat this disorder, called cyclodextrin or HPßCD, may for the first time offer a real treatment. But it can cause significant hearing loss and requires multiple injections directly into the brain, which can be very traumatic. I'm very excited about the potential of our new drug delivery system to address these problems."

The HPßCD drug is attached to an extraordinarily small, nanotech-sized lipid particle that can carry it into cells, where it helps to flush out cholesterol.

However, researchers were surprised to discover that the carrier itself also helped address the problem, while working in synergy with the drug it carries to greatly increase its effectiveness.

This should allow use of much lower dosages and possibly an easier delivery through intravenous injection, instead of brain injection.

In the form currently used, only 0.2 percent of the drug is able to cross the blood brain barrier.

In previous research with the HPßCD drug in animal models, the treatment did slow the progression of this disease, but did not reverse it. The disease focuses its damage on liver and brain cells.

In their report, researchers noted that this type of drug delivery system has several advantages, including prolonged circulation times, the ability to incorporate multiple drugs with different mechanisms of action, and a variety of "targeting ligands" that can help cross the blood brain barrier.

The research was published in Scientific Reports. (ANI)

Rush-hour pollution may be more harmful than thought

Updated: Jul 22, 2017 10:57 IST     

Washington D.C. [USA], Jul 22 (ANI): Turns out, rush-hour commuters may be in for a double whammy of pollution exposure.

Full Story >>

TRAC, MedGenome announce Cancer Immunotherapy solution

Updated: Jul 22, 2017 06:24 IST     

New Delhi [India], July 22 (ANI): Toronto Recombinant Antibody Centre (TRAC) from the University of Toronto, Canada agreed to license MedGenome's patented cancer immunotherapy solution OncoPept to develop biomarkers for their drug candidates against immune modulators to treat cancer.

Full Story >>

Are some people genetically programmed to be depressed?

Updated: Jul 21, 2017 09:48 IST     

Washington D.C. [USA], Jul 21 (ANI): It's a sombre thought, but it seems that some of us are born more likely to be depressed.

Full Story >>

Washington D.C. [USA], Jul 21 (ANI): A team of researchers has come up with a new imaging technique that can diagnose cardiac sarcoidosis much more accurately than traditional tests.

Full Story >>

Ahmedabad (Gujarat) [India], July 21 (ANI): Ayurveda is a form of alternative medicine which seeks to treat and integrate body, mind and spirit using a comprehensive holistic approach especially by emphasizing diet, herbal remedies, exercise, meditation, breathing, and physical therapy.

Full Story >>

Washington D.C. [USA], Jul 20 (ANI): When it comes to faring well after chemotherapy, a cancer patient's social interaction matters, according to a recent study.

Full Story >>

New radiotherapy find offers hope to cancer patients

Updated: Jul 20, 2017 10:06 IST     

Washington D.C. [USA], Jul 20 (ANI): An exciting discovery in the cancer treatment is having dramatic results.

Full Story >>

New strategy could yield more effective flu shots

Updated: Jul 20, 2017 09:46 IST     

Washington D.C. [USA], Jul 20 (ANI): A boosting skin vaccination with a biodegradable microneedle patch and protein constructed from sequences of influenza virus subtypes could improve the effectiveness of conventional influenza vaccines, according to a recent study.

Full Story >>

Revealed! Best time to sleep to wake up feeling refreshed

Updated: Jul 20, 2017 04:09 IST     

London [UK], July 20 (ANI): The secret of a good night's sleep has finally been unveiled!

Full Story >>

Anxiety drug may help you with fear of social rejection

Updated: Jul 19, 2017 14:22 IST     

Washington D.C. [USA], July 19 (ANI): A team of researchers has found that low doses of anxiety disorder-reducing drug can help highly-anxious people overcome their fear of being over-looked and rejected socially.

Full Story >>

Washington D.C. [USA], July 19 (ANI): Good news! A new technology may help to non-invasively predict children or newborn at risk of an asthma attack.

Full Story >>

Your poor sleep may increase risk of Alzheimer's: Study

Updated: Jul 19, 2017 10:08 IST     

Washington D.C. [USA], July 19 (ANI): Beware! Breathing problems during sleep may be a signal of an increased risk for Alzheimer's disease, warns a study.

Full Story >>

Indian population, carrier of hepatitis B: Study

Updated: Jul 18, 2017 20:01 IST     

New Delhi [India], July 18 (ANI): Viral hepatitis is inflammation and damage of the liver by viruses , most commonly hepatotrophic (predominantly with an affinity for attacking the liver - Hepatitis A , B , C , D , E ) or non hepatotrophic viruses (Generalized involvement of human body with liver as a target tissue seen with Dengue virus , Chikungunya etc.).

Full Story >>

This monsoon, let's be HepAware!

Updated: Jul 18, 2017 18:01 IST     

New Delhi [India], July 18 (ANI): Hepatitis A is mild to the moderate viral disorder of the liver which is affected by the consumption of contaminated food and water. Unfortunately, monsoons are the best time when air/water borne infections are at its peak.

Full Story >>

Washington D.C. [USA], July 18 (ANI): If your grandparents are suffering from dementia, then you can help them by interacting with them about their interests for an hour a week and improve their quality life.

Full Story >>

New Delhi [India], July 17 (ANI): Commemorating its 21st Founder's Day and in an endeavor to promote healthy lifestyle, Pushpawati Singhania Hospital & Research Institute (PSRI) a multi-specialty hospital here organized free health check-up camps and school wellness programme.

Full Story >>

Here's how weekly social hour can help dementia patients

Updated: Jul 17, 2017 11:49 IST     

Washington D.C. [USA], Jul 17 (ANI): Person-centred activities combined with just one hour a week of social interaction can improve quality of life and reduce agitation for people with dementia living in care homes, while saving money, according to a recent study.

Full Story >>

Combo therapy better than drug alone against Alzheimer's

Updated: Jul 17, 2017 11:34 IST     

Washington D.C. [USA], Jul 17 (ANI): Combining a specific care management program with a commonly-prescribed drug for Alzheimer's disease is better at turning back the clock on the ageing brain than medication alone, according to a recent study.

Full Story >>

Washington D.C. [USA], Jul 17 (ANI): Nearly 30 percent of stroke patients are refusing to take life-saving statins because they are worried about the side effects, according to a recent study.

Full Story >>

Washington D.C. [USA], Jul 17 (ANI): The terrorist attacks on the World Trade Centre on September 11, 2001 have left behind scars that are more than just skin-deep. According to a recent study, the survivors may be at an increased long-term risk of asthma, other respiratory diseases and heart attack.

Full Story >>